5-(Aminomethyl)oxazolidin-2-one hydrochloride

Catalog No.: 
ACIWES845
CAS No.: 
1638763-83-3
Molecular Formula: 
C4H9ClN2O2
Molecular Weight: 
152.58
5-(Aminomethyl)oxazolidin-2-one hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$88.00In stockIn stock
250mg97%$202.00In stockIn stock
1g97%$561.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Aminomethyl)oxazolidin-2-one hydrochloride
IUPAC Name5-(aminomethyl)oxazolidin-2-one hydrochloride
MDL No.MFCD27986908
Molecular FormulaC4H9ClN2O2
Molecular Weight152.58
SMILESO=C1OC(CN)CN1.[H]Cl
InChI KeyTWOFNQCERHOFJY-UHFFFAOYSA-N
Synonym1638763-83-3 | 5-(Aminomethyl)oxazolidin-2-one hydrochloride | 5-(aminomethyl)-1,3-oxazolidin-2-one hydrochloride | 5-(Aminomethyl)-1,3-oxazolidin-2-one HCl | 5-(aminomethyl)-1,3-oxazolidin-2-one;hydrochloride | MFCD27986908 | 2-Oxazolidinone, 5-(aminomethyl)-, hydro
CAS No.1638763-83-3
PubChem CID91800849

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACIWES845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCNXD137 route compound structure diagram
    ACCNXD13722625-57-6In Stock
  2. Then
  3. ACIWES845 route product structure diagram
    ACIWES8451638763-83-3In Stock
Inquiry

2. ACIWES845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIWES845 route product structure diagram
    ACIWES8451638763-83-3In Stock
Inquiry

3. ACIWES845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIWES845 route product structure diagram
    ACIWES8451638763-83-3In Stock
Inquiry

Comments (0)